TABLE 2.
Details of Venous Thromboembolic Events in MLB Playersa
| Type of VTE | Treatment | Risk Factors Identified | Time Missed From Play, mo | Year of Event | MLB Team |
|---|---|---|---|---|---|
| UE DVT | Surgical removal of first rib | Family history | 7.10 | 2011 | Tampa Bay Rays |
| Anticoagulation therapy, calcium channel blockers | 0.10 | 2012 | Toronto Blue Jays | ||
| Surgical removal of first rib, anticoagulation therapy | 5.20 | 2015 | Atlanta Braves | ||
| Surgical repair, anticoagulation therapy | 7.53 | 2015 | Detroit Tigers | ||
| Surgical repair, anticoagulation therapy | TOS previously with surgical removal of rib in 2001 | 2.83 | 2007 | Detroit Tigers | |
| Surgical removal (angioplasty), anticoagulation therapy | 12.20 | 2008 | Detroit Tigers | ||
| Surgical removal of first rib, anticoagulation therapy (6 mo) | 5.83 | 2013 | Minnesota Twins | ||
| Surgical removal of rib | 3.50 | 1999 | Minnesota Twins | ||
| Surgical removal of clot, vein graft | 3.73 | 2006b | Pittsburgh Pirates | ||
| Surgical removal of clot, anticoagulation therapy | 1.60 | 2013 | Los Angeles Angels | ||
| Surgical removal of clots, anticoagulation therapy | Previous DVT | 3.67 | 2008b | Colorado Rockies | |
| LE DVT | Anticoagulation therapy | 1 wk post ACL, third-degree sprain | 10.87 | 2012 | New York Yankees |
| PE | Anticoagulation therapy | CE | 2011 | Boston Red Sox | |
| Anticoagulation therapy (3-6 mo) | Regular air travel | 29.20 | 2006 | Chicago Cubs | |
| Anticoagulation therapy | 7.63 | 2002 | Texas Rangers | ||
| DVT and PE | Surgical removal of first rib, anticoagulation therapy | 11.90 | 2004 | Colorado Rockies |
aACL, anterior cruciate ligament; CE, career ending; DVT, deep vein thrombosis; LE, lower extremity; MLB, Major League Baseball; PE, pulmonary embolism; TOS, thoracic outlet syndrome; UE, upper extremity; VTE, venous thromboembolism.
bAthlete with recurrent VTE.